Investigator's Brochure (IB) Table

Drugs

Drug Name Drug Company IB Date Risk List Available? Sort descending
Doravirine (MK-1439) Merck January 2020
Tenofovir Alafenamide/Elvitegravir CONRAD July 2019
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) Merck January 2020
Cenicriviroc Mesylate CVC (TBR-652) - New Allergan March 2020
Etravirine (TMC125, Intelence) Janssen Research & Development November 2019
GSK1265744 (Cabotegravir) ViiV Healthcare December 2019
Maraviroc (UK-427857) ViiV Healthcare October 2017
Rifapentine Sanofi August 2013
Rilpivirine (TMC278, Edurant) Janssen Research & Development July 2019
Tenofovir Gel CONRAD January 2013
ABT-267, ABT 333, ABT-450 and Ritonavir AbbVie June 2017
Vorinostat (Zolinza) Merck August 2013
Bedaquiline (TMC207) Janssen Research & Development February 2019
PC-1005 Population Council April 2017
Dapivirine (Microbicide Gel) International Partnership for Microbicides May 2017
Sofosbuvir/Velapatasvir (Epclusa) Gilead July 2016
Dapivirine (Vaginal Ring) International Partnership For Microbicides November 2019
Tenofovir Vaginal Ring CONRAD August 2017
Delamanid (OPC-67683) Otsuka April 2019
Cemiplimab (REGN2810) Regeneron Pharmaceuticals, Inc. May 2019

Vaccines

Vaccine Name Vaccine Company IB Date Risk List Available? Sort descending
HIV-1 Multiantigen pDNA Vaccine and Human IL-12 pDNA Profectus BioSciences August 2018
10-1074 Rockefeller University/Mass Biologics September 2019
MVA-CMDR Walter Reed Army Institute Research (WRAIR) November 2019
SAR441236 Sanofi June 2018
p24CE1/2 multivalent pDNA Vaccine expressing HIV M Group p24 Gag and p55 gag pDNA with IL-12 pDNA NCI/NIAID/NIH November 2017
GEO-D02 and MVA-HIV62B Vaccine GeoVax June 2019
PENNVAX-GP and IL-12 DNA Inovio Parmaceuticals December 2016
CH505TF gp120 Transient DAIDS/NIAID/NIH December 2018
Recombinant oligomeric gp145 C.6980 Clade C HIV Env protein NIH/NIAID August 2017
RSV 6120/DeltaNS2/1030s LID/NIAID/NIH March 2019
RSV 276 LID/NIAID/NIH February 2019
PGT121 Beth Israel Deaconess Medical Center January 2019
Bivalent Subtype C gp120 with Aluminum Hydroxide Adjuvant NIAID/NIH June 2015
RSV DeltaNS2-Delta1313-I1314L LID/NIAID/NIH February 2019
PGDM1400 Beth Israel Deaconess Medical Center August 2018
Bivalent Subtype C gp120/AS01B GlaxoSmithKline July 2016
rVSV HIV Vaccines Profectus BioSciences January 2016
MPER-656 Liposomes with Aluminum Hydroxide Suspension DAIDS/NIAID/NIH February 2019
Bivalent Subtype C gp120/MF59 GlaxoSmithKline July 2016
IHV01 Profectus BioSciences Inc. March 2019